STOCKHOLDERS' EQUITY (Details)			12 Months Ended
	Dec. 14, 2020 USD ($) $ / shares shares	May 29, 2020 USD ($) $ / shares	Dec. 31, 2020 USD ($) $ / shares shares	Oct. 04, 2020 USD ($)	Jun. 01, 2020 USD ($)	Mar. 31, 2020 $ / shares
STOCKHOLDERS' EQUITY
Exercise price of warrants | $ / shares						$ 1.00
2020 Capital Raise
STOCKHOLDERS' EQUITY
Conversion ratio		75
Exercise price of warrants | $ / shares	$ 0.4917	$ 0.5565
Warrants and rights outstanding, term		5 years
Debt issuance costs, net		$ 2,173,074
Warrants exercisable (in shares) | shares			0
Beneficial ownership limitation (as a percent)			9.99%
Notice period			61 days
Deemed dividends	$ 732,494
Proceeds from sale of securities			$ 3,000,000
Shares of common stock sold | shares			7,532,010
Sale of stock, purchase price per share | $ / shares		$ 0.3983	$ 0.5565
Warrants to purchase | shares	1,631,000		5,649,007
Outstanding balances of existing holders for which the Company will seek an extended maturity date				$ 2,331,000	$ 2,331,000
Amount of notes with extended maturity date				$ 600,000
Exercise price, as a percentage of common stock price		100.00%
2020 Capital Raise | Minimum
STOCKHOLDERS' EQUITY
Proceeds from sale of securities		$ 2,185,000
Exercise price of additional warrants | $ / shares		$ 0.45
2020 Capital Raise | Maximum
STOCKHOLDERS' EQUITY
Proceeds from sale of securities		$ 3,000,000
Exercise price of additional warrants | $ / shares		$ 0.56